id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-N-0096-0005,FDA,FDA-2003-N-0096,Guidance for Industry; Manufacturing Biological Intermediates and Biological Drug Substances Using Spore-Forming Microorganisms,Supporting & Related Material,Guidance,2007-09-07T04:00:00Z,2007,9,,,2025-06-18T19:52:56Z,,0,0,0900006480483927
FDA-2003-N-0096-0006,FDA,FDA-2003-N-0096,"""Guidance for Industry: Manufacturing Biological Intermediates and Biological Drug Substances Using Spore-Forming Microorganisms""; Availability",Notice,Notice of Data Availability,2007-09-07T04:00:00Z,2007,9,2007-09-07T04:00:00Z,,2025-06-18T19:32:10Z,E7-17709,0,0,090000648048392a
FDA-2003-N-0096-0004,FDA,FDA-2003-N-0096,"Draft Guidance for Industry: Manufacturing Biological Drug Substances, Intermediates, or Products Using Spore-Forming Microorganisms; Availability",Notice,Notice of Data Availability,2005-03-03T05:00:00Z,2005,3,2005-02-24T05:00:00Z,2005-05-26T03:59:59Z,2025-06-18T19:26:25Z,05-3593,0,0,090000648048390b
FDA-2003-N-0096-0003,FDA,FDA-2003-N-0096,"Guidance for Industry; Manufacturing Biological Drug Substances, Intermediates, or Products Using Spore-Forming Microorganisms; Draft Guidance",Supporting & Related Material,Background Material,2005-03-03T05:00:00Z,2005,3,,,2025-06-18T19:48:43Z,,0,0,0900006480483907
FDA-2003-N-0096-0001,FDA,FDA-2003-N-0096,Revision of the Requirements for Spore-Forming Microorganisms,Notice,NPR-Notice of Proposed Rule-Making,2003-12-30T05:00:00Z,2003,12,2003-12-30T05:00:00Z,2004-03-16T04:59:59Z,2025-06-19T09:00:11Z,03-31919,0,0,09000064804838aa
FDA-2003-N-0096-0002,FDA,FDA-2003-N-0096,Revision of the Requirements For Spore-Forming Microorganisms; Companion to Direct Final Rule,Notice,Notice of Final Rule,2003-12-30T05:00:00Z,2003,12,2003-12-30T05:00:00Z,2004-03-16T04:59:59Z,2025-06-18T19:14:55Z,03-31918,0,0,09000064804838f1